Published guidance, NICE advice and quality standards | Guidance

Showing 31 to 40 of 302

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care	DG56	24 August 2023	24 August 2023
Selpercatinib for untreated RET fusion-positive advanced non-small-cell lung cancer	TA911	26 July 2023	26 July 2023
Lorlatinib for untreated ALK-positive advanced non-small-cell lung cancer	TA909	12 July 2023	12 July 2023
Olaparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube or peritoneal cancer after 2 or more courses of platinum-based chemotherapy	TA908	5 July 2023	5 July 2023
Irreversible electroporation for treating prostate cancer	IPG768	5 July 2023	5 July 2023
Oesophago-gastric cancer: assessment and management in adults	NG83	24 January 2018	4 July 2023
Darolutamide with androgen deprivation therapy and docetaxel for treating hormone-sensitive metastatic prostate cancer	TA903	21 June 2023	21 June 2023
Pembrolizumab with lenvatinib for previously treated advanced or recurrent endometrial cancer	TA904	21 June 2023	21 June 2023
Cemiplimab for treating recurrent or metastatic cervical cancer (terminated appraisal)	TA901	20 June 2023	20 June 2023
Dabrafenib plus trametinib for treating BRAF V600 mutation-positive advanced non-small-cell lung cancer	TA898	14 June 2023	14 June 2023